Literature DB >> 7789948

Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms.

S Kumar1, D L White, S Takai, S Turczynowicz, C A Juttner, T P Hughes.   

Abstract

Developmentally regulated mouse gene Nedd2 encodes a protein similar to the product of the nematode Caenorhabditis elegans cell death gene ced-3 and the mammalian interleukin-1 beta-converting enzyme. Overexpression of Nedd2 in cultured mammalian cells induces apoptosis that can be blocked by proto-oncogene BCL2. We have isolated cDNA clones for the human homologue of the mouse gene and, by using these as probes, mapped the human NEDD2 gene to 7q34-35 by fluorescence in situ hybridisation. The potential tumour suppressor function of NEDD2 is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789948     DOI: 10.1007/bf00209480

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  Identification of a set of genes with developmentally down-regulated expression in the mouse brain.

Authors:  S Kumar; Y Tomooka; M Noda
Journal:  Biochem Biophys Res Commun       Date:  1992-06-30       Impact factor: 3.575

2.  High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones.

Authors:  P Lichter; C J Tang; K Call; G Hermanson; G A Evans; D Housman; D C Ward
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

3.  Location of gene for beta subunit of human T-cell receptor at band 7q35, a region prone to rearrangements in T cells.

Authors:  M Isobe; J Erikson; B S Emanuel; P C Nowell; C M Croce
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

4.  Chromosomal localization of the human T cell receptor beta-chain genes.

Authors:  M M Le Beau; M O Diaz; J D Rowley; T W Mak
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

5.  Human high-affinity Fc gamma RI (CD64) gene mapped to chromosome 1q21.2-q21.3 by fluorescence in situ hybridization.

Authors:  S Takai; M Kasama; K Yamada; N Kai; N Hirayama; H Namiki; T Taniyama
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

6.  Mapping of the KREV1 transformation suppressor gene and its pseudogene (KREV1P) to human chromosome 1p13.3 and 14q24.3, respectively, by fluorescence in situ hybridization.

Authors:  S Takai; N Nishino; H Kitayama; Y Ikawa; M Noda
Journal:  Cytogenet Cell Genet       Date:  1993

7.  Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.

Authors:  W L Neuman; C M Rubin; R B Rios; R A Larson; M M Le Beau; J D Rowley; J W Vardiman; J L Schwartz; R A Farber
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

8.  Genes for beta chain of human T-cell antigen receptor map to regions of chromosomal rearrangement in T cells.

Authors:  C C Morton; A D Duby; R L Eddy; T B Shows; J G Seidman
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

Review 9.  Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.

Authors:  B Johansson; F Mertens; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1993-12       Impact factor: 5.006

10.  Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

Authors:  M Miura; H Zhu; R Rotello; E A Hartwieg; J Yuan
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  13 in total

1.  Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.

Authors:  Keqin Ren; Jing Lu; Aleksey Porollo; Chunying Du
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 2.  Old, new and emerging functions of caspases.

Authors:  S Shalini; L Dorstyn; S Dawar; S Kumar
Journal:  Cell Death Differ       Date:  2014-12-19       Impact factor: 15.828

3.  DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis.

Authors:  Q Song; S P Lees-Miller; S Kumar; Z Zhang; D W Chan; G C Smith; S P Jackson; E S Alnemri; G Litwack; K K Khanna; M F Lavin
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

4.  A tumor suppressor function for caspase-2.

Authors:  Lien Ha Ho; Robyn Taylor; Loretta Dorstyn; Dimitrios Cakouros; Philippe Bouillet; Sharad Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

Review 5.  Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?

Authors:  Sharad Kumar
Journal:  Nat Rev Cancer       Date:  2009-11-05       Impact factor: 60.716

Review 6.  Caspase-2 as a tumour suppressor.

Authors:  J Puccini; L Dorstyn; S Kumar
Journal:  Cell Death Differ       Date:  2013-06-28       Impact factor: 15.828

7.  Prevalence of Chromosome 7 Abnormalities in Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single Center Study and Brief Literature Review.

Authors:  Ruchi Gupta; Shivangi Harankhedkar; Khaliqur Rahman; Manish K Singh; Dinesh Chandra; Navkirti Mittal; Anshul Gupta; Soniya Nityanand
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-05       Impact factor: 0.900

8.  The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd.

Authors:  L Peintner; L Dorstyn; S Kumar; T Aneichyk; A Villunger; C Manzl
Journal:  Cell Death Differ       Date:  2015-04-10       Impact factor: 15.828

Review 9.  The role of caspase-2 in stress-induced apoptosis.

Authors:  Lisa Bouchier-Hayes
Journal:  J Cell Mol Med       Date:  2010-02-16       Impact factor: 5.310

10.  The enigmatic roles of caspases in tumor development.

Authors:  Richard Jäger; Ralf M Zwacka
Journal:  Cancers (Basel)       Date:  2010-11-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.